DM
Deerfield Management Portfolio holdings
AUM
$6.52B
1-Year Est. Return
13.67%
1 Year Est. Return
+13.67%
AUM
$6.52B
AUM Growth
+$1.02B
(+18%)
Holding
173
Top Buys
| 1 | +$209M | |
| 2 | +$130M | |
| 3 | +$105M | |
| 4 |
Cogent Biosciences
COGT
|
+$92.1M |
| 5 |
Inspire Medical Systems
INSP
|
+$67.4M |
Top Sells
| 1 | +$250M | |
| 2 | +$86.3M | |
| 3 | +$48.1M | |
| 4 |
IDEAYA Biosciences
IDYA
|
+$48M |
| 5 |
Baxter International
BAX
|
+$42.8M |
Sector Composition
| 1 | Healthcare | 91.92% |
| 2 | Real Estate | 0.38% |
| 3 | Financials | 0.07% |
| 4 | Consumer Staples | 0.07% |
| 5 | Consumer Discretionary | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Nuvalent
NUVL
$8.26B
| $1.56B | 23.75% |
17,991,024
|
|
||
2
Centene
CNC
$18.6B
| $323M | 4.93% |
9,046,000
+5,860,630
|
|
||
3
Merus
MRUS
$7.28B
| $287M | 4.38% |
3,046,916
-337,712
|
|
||
4
Viatris
VTRS
$12.3B
| $239M | 3.64% |
24,099,083
+75,176
|
|
||
5
United Therapeutics
UTHR
$20.7B
| $179M | 2.73% |
425,993
-114,633
|
|
||
6
Revolution Medicines
RVMD
$14.7B
| $170M | 2.6% |
3,650,342
+266,270
|
|
||
7
Indivior
INDV
$4.2B
| $168M | 2.57% |
6,986,811
-3,580,349
|
|
||
8
Neurocrine Biosciences
NBIX
$15B
| $166M | 2.54% |
1,184,345
+16,543
|
|
||
|
9
Cogent Biosciences
COGT
$6.1B
| $130M | 1.98% |
9,053,118
+6,412,903
|
|
||
10
Ionis Pharmaceuticals
IONS
$13.3B
| $130M | 1.98% |
+1,979,669
|
|
||
11
NewAmsterdam Pharma
NAMS
$4.49B
| $121M | 1.85% |
4,266,693
-849,260
|
|
||
12
Vera Therapeutics
VERA
$2.11B
| $106M | 1.62% |
3,641,157
+293,040
|
|
||
13
Bristol-Myers Squibb
BMY
$100B
| $105M | 1.61% |
+2,337,771
|
|
||
14
AdaptHealth
AHCO
$1.32B
| $103M | 1.57% |
11,477,730
+1,572,835
|
|
||
15
Larimar Therapeutics
LRMR
$304M
| $98.9M | 1.51% |
30,606,974
+9,375,000
|
|
||
16
Brookdale Senior Living
BKD
$2.63B
| $98.6M | 1.51% |
11,641,642
-3,720,622
|
|
||
17
Catalyst Pharmaceutical
CPRX
$2.79B
| $98M | 1.5% |
4,974,767
+2,095,291
|
|
||
18
Legend Biotech
LEGN
$4.96B
| $96.6M | 1.47% |
2,962,338
|
|
||
19
BioCryst Pharmaceuticals
BCRX
$1.5B
| $92.4M | 1.41% |
12,169,000
+7,477,000
|
|
||
20
Merck
MRK
$253B
| $86.4M | 1.32% |
1,030,000
+172,276
|
|
||
21
Pfizer
PFE
$144B
| $84.2M | 1.29% |
3,303,790
-1,002,474
|
|
||
22
Certara
CERT
$1.41B
| $82.4M | 1.26% |
6,739,537
+2,813,438
|
|
||
|
23
Inspire Medical Systems
INSP
$3.67B
| $77.7M | 1.19% |
1,047,694
+907,694
|
|
||
24
ARS Pharmaceuticals
SPRY
$929M
| $75.4M | 1.15% |
7,503,812
-2,220,696
|
|
||
25
Insmed
INSM
$45.1B
| $67.8M | 1.04% |
471,000
-229,700
|
|